Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Gaudreau

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Cluster of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subsp. jejuni from 1999 to 2001 in men who have sex with men, Québec, CanadaChristiane Gaudreau, Sophie Michaud
Antimicrobial Agents and Chemotherapy|May 23, 2003
Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montréal, CanadaChristiane Gaudreau, Huguette Gilbert
Journal of Clinical Microbiology|January 9, 2003
Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000Carole Tremblay, Christiane Gaudreau, Manon Lorange
Journal of Clinical Microbiology|April 25, 2014
Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli isolates obtained in Montreal, Quebec, Canada, from 2002 to 2013Christiane Gaudreau, France Boucher, Huguette Gilbert, et al.
Journal of Clinical Microbiology|November 26, 2010
First case of invasive human infection caused by Cupriavidus metalliduransStéphanie Langevin, Jean Vincelette, Sadjia Bekal, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2007
Comparison of disk diffusion and agar dilution methods for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni subsp. jejuniChristiane Gaudreau, Yves Girouard, Louise Ringuette, et al.
The Journal of Infectious Diseases|May 18, 2005
Mechanisms underlying Campylobacter fetus pathogenesis in humans: surface-layer protein variation in relapsing infectionsZheng-Chao Tu, Christiane Gaudreau, Martin J Blaser
Journal of Medical Microbiology|January 5, 2002
Comparison of SmaI-defined genotypes of Campylobacter jejuni examined by KpnI: a population-based studySophie Michaud, Suzanne Menard, Christiane Gaudreau, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2008
Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuniChristiane Gaudreau, Yves Girouard, Huguette Gilbert, et al.
Canadian Journal of Microbiology|January 4, 2024
Inhibition of the type IV secretion system from antibiotic-resistant <i>Helicobacter pylori</i> clinical isolates supports the potential of Cagα as an anti-virulence targetFlore Oudouhou, Claire Morin, Mickael Bouin, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Cluster of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subsp. jejuni from 1999 to 2001 in men who have sex with men, Québec, CanadaChristiane Gaudreau, Sophie Michaud
Antimicrobial Agents and Chemotherapy|May 23, 2003
Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montréal, CanadaChristiane Gaudreau, Huguette Gilbert
Journal of Clinical Microbiology|January 9, 2003
Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000Carole Tremblay, Christiane Gaudreau, Manon Lorange
Journal of Clinical Microbiology|April 25, 2014
Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli isolates obtained in Montreal, Quebec, Canada, from 2002 to 2013Christiane Gaudreau, France Boucher, Huguette Gilbert, et al.
Journal of Clinical Microbiology|November 26, 2010
First case of invasive human infection caused by Cupriavidus metalliduransStéphanie Langevin, Jean Vincelette, Sadjia Bekal, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2007
Comparison of disk diffusion and agar dilution methods for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni subsp. jejuniChristiane Gaudreau, Yves Girouard, Louise Ringuette, et al.
The Journal of Infectious Diseases|May 18, 2005
Mechanisms underlying Campylobacter fetus pathogenesis in humans: surface-layer protein variation in relapsing infectionsZheng-Chao Tu, Christiane Gaudreau, Martin J Blaser
Journal of Medical Microbiology|January 5, 2002
Comparison of SmaI-defined genotypes of Campylobacter jejuni examined by KpnI: a population-based studySophie Michaud, Suzanne Menard, Christiane Gaudreau, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2008
Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuniChristiane Gaudreau, Yves Girouard, Huguette Gilbert, et al.
Canadian Journal of Microbiology|January 4, 2024
Inhibition of the type IV secretion system from antibiotic-resistant <i>Helicobacter pylori</i> clinical isolates supports the potential of Cagα as an anti-virulence targetFlore Oudouhou, Claire Morin, Mickael Bouin, et al.
Pageof 3